I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
N-Acetyl-Ser-Asp-Lys-Pro inhibits the entry of pluripotent hemopoietic stem cells into S-phase of the cell cycle and protects against Ara-C lethality in mice. It is a specific substrate for the N-terminal active site of angiotensin converting enzyme, which is responsible for its degradation in vivo.
C S Anthony; G Masuyer; E D Sturrock; K R Acharya. Structure based drug design of angiotensin-I converting enzyme inhibitors. Current Medicinal Chemistry.2012, 19, (6), 845-855.
A Rousseau-Plasse; J Wdzieczak-Bakala; M Lenfant; E Ezan, R Genet; S Robinson; T Briscoe; J Melville; A Riches. Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo. Experimental Hematology.1998, 26, (11), 1074-1079.